2026-01-02 - Analysis Report
Okay, let's break down the analysis of UNH (UnitedHealth Group Inc.), a managed healthcare company.

**1) Return Rate Comparison & Alpha/Beta Analysis:**

*   **Company Overview:** UnitedHealth Group is a diversified healthcare company providing health benefits and healthcare services.
*   **UNH Cumulative Return:** -21.89%
*   **S&P 500 (VOO) Cumulative Return:** 91.40%
*   **Divergence:** Current: -127.0, Relative Divergence: 6.7

    *   The significant negative divergence indicates UNH has drastically underperformed the S&P 500 over the covered period. The relative divergence of 6.7 suggests this underperformance is near the lower end of its historical range compared to VOO.

*   **Alpha, Beta, and CAGR Analysis:**

    | Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
    |------------|---------|-------|---------|-------|--------|
    | 2016-2018  | 22.0%   | 82.4% | 19.0%   | 0.9   | 225.7  |
    | 2017-2019  | 27.0%   | 91.1% | 10.0%   | 0.9   | 266.3  |
    | 2018-2020  | -41.0%  | 99.8% | -62.0%  | 1.1   | 317.7  |
    | 2019-2021  | 16.0%   | 99.8% | -27.0%  | 1.1   | 454.9  |
    | 2020-2022  | 0.0%    | 99.8% | 2.0%    | 0.9   | 480.3  |
    | 2021-2023  | 23.0%   | 65.3% | 23.0%   | 0.5   | 476.9  |
    | 2022-2024  | -24.0%  | 84.0% | -44.0%  | 0.4   | 458.2  |
    | 2023-2025  | -55.0%  | 98.5% | -118.0% | 0.3   | 299.0  |

    *   **CAGR:** The Compound Annual Growth Rate shows fluctuating performance.  Recent periods (2018-2020, 2022-2025, 2023-2025) have been significantly negative.
    *   **MDD:** Maximum Drawdown is high across all periods, indicating substantial potential for loss from peak to trough.
    *   **Alpha:** Alpha, representing risk-adjusted outperformance relative to the benchmark, is largely negative in recent years, highlighting UNH's underperformance.
    *   **Beta:** Beta has decreased significantly in recent periods, with 0.3 in the 2023-2025, suggesting UNH has become less sensitive to overall market movements (VOO).
    *   **Cap(B):** Market capitalization peaked in the 2020-2022 range, then has been decreased significantly.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 330.11
*   **Previous Close:** 332.16, Change: -0.62
*   **5-day SMA:** 330.124
*   **20-day SMA:** 331.067
*   **60-day SMA:** 337.7943

    *   The stock price is slightly down compared to the previous close.  The 5-day SMA is slightly below the 20-day SMA, and both are below the 60-day SMA, which *could* indicate a short-term downward trend.

**3) Technical Indicators & Expected Return:**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 51.90 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.0659
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21
*   **Recent (20 days) relative divergence change:** 1.9 (+): 단기상승 (Short-term Increase)
*   **Expected Return:** 0.0%

    *   The MRI suggests a medium level of investment risk.
    *   The RSI is neutral.
    *   The PPO suggest that the stock is neither overbought or oversold.
    *   The "Short-term Increase" suggests a minor recent upward trend.
    *   The 0% Expected Return is concerning, implying no projected excess return compared to the S&P 500 for long-term investment from the current point.

**4) Recent News & Significant Events:**

*   **Negative News:**
    *   UnitedHealthcare delays remote monitoring policy (ts2.tech).
    *   Forbes highlights risks that can make UNH unattractive.
*   **Positive/Neutral News:**
    *   Seeking Alpha argues the bull case is still standing tall (Seeking Alpha).
    *   UNH vs. ELV comparison (Yahoo Finance).
    *   UNH rises after hours as traders look ahead to January guidance (ts2.tech).
*   **Other News:**
    *   Billionaire David Tepper Sells These 5 Stocks to Buy This 1 Stock (24/7 Wall St.) - the article does not specify what stock he buys.

    *   **Analysis:** Recent news is a mixed bag. The delayed monitoring policy and Forbes article highlighting risks are potential negatives. However, the Seeking Alpha article maintains a positive outlook, and the article about traders anticipating January guidance suggests some optimism. The Tepper article needs further analysis to understand the impact.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.96)
*   **Opinions:** 25
*   **Target Price (avg/high/low):** 392.24 / 440.00 / 280.00
*   **Recent Rating Changes:** No changes reported

    *   Analysts are generally positive on UNH, with a "Buy" consensus and an average target price significantly above the current price. However, a wide range between high and low target prices indicates uncertainty.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-10-28 | 2.59  | 113.16 B$   |
| 2025-08-11 | 3.76  | 111.62 B$   |
| 2025-05-07 | 6.9   | 109.58 B$   |
| 2024-11-04 | 6.56  | 100.82 B$   |
| 2025-10-28 | 6.56  | 100.82 B$   |

    *   While revenue has been growing steadily, the most recent EPS (2.59) is significantly lower than the previous quarters. This discrepancy needs further investigation to understand the reasons behind the drop.

**6) Financial Information (Revenue/Profitability & Capital/Profitability):**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-09-30   | $113.16B    | 18.24%       |
| 2025-06-30   | $111.62B    | 17.93%       |
| 2025-03-31   | $109.58B    | 21.70%       |
| 2024-12-31   | $100.81B    | 21.14%       |
| 2024-09-30   | $100.82B    | 22.84%       |

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-09-30   | $95.79B    | 2.45%   |
| 2025-06-30   | $94.72B    | 3.60%   |
| 2025-03-31   | $95.04B    | 6.62%   |
| 2024-12-31   | $92.66B    | 5.98%   |
| 2024-09-30   | $94.53B    | 6.41%   |

*   **Revenue:** Revenue is on a clear upward trend.
*   **Profit Margin:** Profit margins have decreased in recent quarters, aligning with the lower recent EPS.
*   **Equity:** Equity is relatively stable.
*   **ROE:** Return on Equity (ROE) has fallen significantly, reinforcing the concerns raised by the lower EPS and profit margin.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** UNH has significantly underperformed the S&P 500 recently.
*   **Financial Concerns:** While revenue is growing, there are concerning trends in recent EPS, profit margins, and ROE.  A deeper dive into the cause of these declines is warranted.
*   **Mixed News:** News is mixed with some negative headlines offsetting positive analyst sentiment.
*   **Analyst Optimism vs. Technicals:** Analysts have a "Buy" rating with a higher target price, but the technical indicators and recent price action suggest caution. The lack of expected return suggests limited future growth.
*   **MRI is Medium:** The market risk indicator suggests a medium level of investment risk, however the high maximum drawdown statistics suggest a much higher risk.
*   **Moving Averages:** The moving averages indicate a short-term downtrend, so UNH is more likely to decline.
*   **Recommendation:** The data paints a complex picture. While analyst ratings are positive, the underperformance, declining profitability metrics, and mixed news suggest investors should exercise caution. Further research is needed to understand the drivers behind the recent financial challenges before making an investment decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.